State Transparency Pricing Sheets
Colorado
In accordance with the Colorado Wholesale Acquisition Cost Disclosure Law (Colorado Revised Statutes Section 12-42.5-308), Asahi Kasei Therapeutics is disclosing to authorized prescribers of prescription drugs in Colorado the wholesale acquisition cost (WAC) pricing for its medicines.
| ENVARSUS XR® (tacrolimus extended release tablets) | WAC Information |
| TARPEYO® (budesonide delayed release capsules) | WAC Information |
Connecticut
In accordance with Connecticut Public Act No. 23-171, Asahi Kasei Therapeutics is disclosing to prescribing practitioners and pharmacists in Connecticut certain required wholesale acquisition cost (WAC) pricing for its medicines.
| ENVARSUS XR® (tacrolimus extended release tablets) | WAC Information |
| TARPEYO® (budesonide delayed release capsules) | WAC Information |
Vermont
In accordance with Vermont Pharmaceutical Marketer Price Disclosure Law 18 V.S.A. Section 4633, Asahi Kasei Therapeutics is disclosing to authorized prescribers of prescription drugs in Vermont certain required average wholesale price (AWP) pricing information for its medicines.
| ENVARSUS XR® (tacrolimus extended release tablets) | Long Form | Short Form |
| TARPEYO® (budesonide delayed release capsules) | Long Form | Short Form |